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Performance and cost-effectiveness of
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diagnostic test (RDT) kits in diagnosis of dengue
infection in resource limited set up
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Background: Dengue infection occurs amongmore than50mil-
lion annually. In India, the case fatality rate is up to 3-5%. Early
diagnosis is crucial to the clinical care. However the currently rec-
ommended diagnostic tests by WHO is costly, time consuming,
labor and technologically demanding which may not be available
in the resource limited set up where the large burden of dengue
related illness occur.
This study evaluated the role of immunochromatographic
method based rapid diagnostic test kits (RDT) and cost-
effectiveness for the diagnosis of acute dengue infection.
Methods & Materials: 281 adult patients presenting to Chris-
tianMedical College, Vellore, Indiawith community acquired acute
febrile illness between September 2012 to February 2013 were
recruited for the study. The patients with other proven etiology
were used as negative control. 132 cases of dengue and 149 cases of
non-dengue infection were enrolled. The RDTs tested from 4 man-
ufacturers were Panbio, SD, J.Mitra and Reckon. SPSS version 16.0.1
was used for statistical analysis.
Results: Performance of the RDTs based on IgM: The sensitiv-
ity, speciﬁcity, PPV and NPV of Panbio, SD, Reckon and J.Mitra. The
inter-rater kappa agreement between Panbio with SD duo of 0.54
was found to be moderate.
Performance of the RDTs based on NS1 detection: The sensi-
tivity, speciﬁcity, PPV and NPV of the SD, Reckon, and J.Mitra. The
inter-rater kappa agreement between SD with Reckon of 0.79 was
found to be best and substantial.
Combination of RDTs: the best sensitivity of 99.2%was achieved
by testing Panbio and SD in parallel. The best speciﬁcity of 99.9%
and 100% respectively was obtained when Reckon with Panbio or
SD was performed in series.
None of the RDTs could not adequately differentiate between
acute primary and secondary dengue.
Conclusion: In the region of high dengue endemicity, Panbio
RDT alone is highly sensitive, cost effective (∼13.6 USD), easier
to perform and shorter turnover time makes it a test of choice in
resource limited set up during an outbreak season.
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Hepatitis C viral infection in our region
E. Dimitrovska
Clinical Hospital, Bitola, Macedonia
Background: To present the basic characteristics of Hepatitis C
viral infection (HCVi) in the region of Bitola, Republic ofMacedonia,
in the period from October 2010 to October 2013.
Methods & Materials: Past medical history, epidemiological
data, standard biochemical analyses, Elisa antibodies, PCR, and liver
biopsy, were used in order to set the diagnoses. 74 patients had
been analyzed:49 male (66.22%) and 25 female (33.78%). Accord-
ing to age, the patients were between 18 and 65 years old. All of
themwere from theurban area. 52 patients (70%)were intravenous
drug abusers.
Results: Hepatitis C virus (HCV) genotype 1 was diagnosed
in 23 patients (31%), and HCV genotype 3 in 51 patients (69%).
The patients were treated with Peg-interferon alfa 2-a/Ribavirine
under current standards (180 mcg once weekly/1200mg daily),
during 24 or 48 weeks. Therapy was completed in 49 patients
(66%). In 6 patients (8%) therapy was not completed due to the side
effects (generalized urticaria, pancitopaenia, colon neoplasm), and
19 patients (26%) are still receiving therapy. SVRwere documented
in all of the patients.
Conclusion: Accordding to sex, most of the patients were male:
49 (66.22%). Most of the patients were intravenous drug abusers:
52 (70%). According to age, most of the patients were between 18
and 30 years old: 58 (78%). HCVi became a great problem in our
region in the recent years, especially among the young population
and intravenous drug abusers.
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Background: Human cytomegalovirus (HCMV) is a double
stranded DNA virus in the Herpesviridae family latently infecting
60-100% of world population. A severe HCMV disease is associ-
atedwith congenital infection and immunosuppression. TheHCMV
major envelope glycoprotein gB is involved in the host cell entry,
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cell-to-cell transmission and fusion of infected cells. The gB gly-
coprotein is an important target for both humoral and cellular
immune responses and included in the HCMV vaccine develop-
ment. HCMV gB gene is classiﬁed into four genotypes; namely
genotype 1, 2, 3 and 4. All gB genotypes were implicated in the
disease severity of transplant recipients and HIV infected patients.
Aim: To analyse the gene proﬁle and construct the phyloge-
netic tree of HCMV gB gene sequences obtained from HIV infected
patients who were experiencing HCMV viraemia to document the
circulating HCMV gB genotypes in South Africa.
Methods & Materials: Nested PCR method targeting vari-
able region of gB gene was developed and gB gene sequences
were ampliﬁed from twenty archived plasma samples of HCMV
viraemic HIV infected patients. Analysis of nucleotide sequences
were performed by using Chromas-Pro software programme and
phylogenetic tree was constructed by comparing with standard
sequences from Genbank, NCBI.
Results: The gB2 genotype was detected in 35% (7/20) of
patients and only 15% (3/20) represents gB1. The gB3 and gB4 geno-
types were identiﬁed among 20% (4/20) and 30% (6/20) of patients
respectively. All gB gene sequences obtained from study partici-
pants displayed98%-100% similaritywith laboratory strainsAD169
andTowneaswell as other reference sequences obtained fromclin-
ical cases. All participants were severely immunosuppressed and
their mean CD4+ T-cell counts was 32 cells/l.
Conclusion: All four gB genotypes circulate in the study popu-
lation and gB 2 genotype is a dominant genotype. High sequence
similarity between study samples and vaccine strain indicates that
our population will have positive response should the HCMV gB
vaccine becomes available in South Africa.
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Varicella zoster virus encephalitis in an
immunocompetent woman
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Background: Varicella Zoster Virus (VZV)may causemany cen-
tral nervous system diseases such as cerebellar ataxia, myelitis,
meningitis or encephalitis. The information regarding clinical fea-
tures of VZV encephalitis is limited.
Methods&Materials: A 52 year old female patient presentwith
fever and altered consciousness.
Results: She had high fever and nausea for 4 days and had
been admitted to a hospital with these complaints before, second
generation cephalosporin had been administered for upper respi-
ratory tract infection. Third days of this therapy, aphasia, inability
to communication and lethagy developed. She was admitted to our
emergency department. In physical examination she had altered
consciousness, aphasia and neck stiffness. It was learnt that her
neighbour had a zona infection recently but she did not remem-
ber exact time. Her WBC level was 9800K/uL, CRP was 2,38mg/dL
(0-0,8), procalcitonin was 0,18ng/mL (0,5-2,0). CSF pressure was
mildly elevated; there was 400 leukocyte/mm3 with lympho-
cyte predominance. CSF glucose level was 47mg/dL and protein
level was 151mg/dL (15-45), at the same time her blood glucose
level was 114mg/dL. Intravenous ceftriaxone2×2 gr and acyclovir
3×10mg/kg/day were started. She became conscious on the ﬁrst
day of the treatment. On the third day she had visual hallucina-
tions and disarthria, she underwent second spinal tap. The CSF
pressure was mildly elevated, glucose was 89mg/dl (blood glucose
level was 114mg/dL) and protein was 271mg/dL. There were 520
leukocyte/mm3. The patient had anxiety and was disoriented; on
the follow up she became better. VZV PCR was reported as posi-
tive in the CSF sample that was sent to an outside laboratory to
investigate viral pathogens. Acyclovir was stopped on the 14th day.
She had a complaint of fast speaking and emotional lability in the
follow-up controls for 3 months.
Conclusion: Less common causes of viral encephalitis include
VZV, with an incidence of 1 in 2000 infected persons. Acyclovir was
recommended for but duration of therapy was not standart in the
literature.
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Seroprevalence of foot and mouth disease in
Tanzania
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Background: Foot and Mouth disease (FMD) in Tanzania is a
major obstacle to the development of the national livestock indus-
try because of its adverse effect in livestock production and trade
of animal and animal products into lucrative export market.
The study aimed at documenting the prevalence of foot and
mouth disease (FMD) in the two different ecosystem (Wildlife-
livestock interface areas and non interface areas) where pastoral
and Agropastoral mode of livestock rearing is predominant in Tan-
zania.
Methods & Materials: A cross sectional study was conducted
on Serengeti ecosystem (Wildlife-livestock Interface) and Central
part of Tanzania (Non interface) to determine the prevalence of foot
and mouth disease (FMD) in Serengeti, Bunda, Kongwa and Iramba
districts.
Seroprevalence investigation was performed using 3 ABC-ELISA
technique.
Results: The results showed that the overall prevalence of
foot and mouth disease (FMD) was 66.25% (265/400). Signiﬁcantly
higher prevalence was recorded in wildlifelivestock-interface area
71.5% (143/200) compared to non interface area 61% (122/200)
(x2 =4.9308, P =0.0264). However district wise higher prevalence
was recorded in Kongwa district 89% (89/100), Serengeti 78%
(78/100), Bunda 65% (65/100) and Iramba 33% (33/100) respec-
